Medical Marijuana Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Aurora Inc., Canopy Growth Corp., Charlottes Web Holdings

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Medical Marijuana pipeline constitutes 25+ key companies continuously working towards developing 50+ Medical Marijuana treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Medical Marijuana Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Medical Marijuana Market.

The Medical Marijuana Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Medical Marijuana Pipeline Report: https://www.delveinsight.com/sample-request/medical-marijuana-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Medical Marijuana treatment therapies with a considerable amount of success over the years.
• Medical Marijuana companies working in the treatment market are InMed Pharmaceuticals, Tilray, Centrexion Therapeutics, Emerald Health, Botanix Pharmaceuticals, Zynerba Pharmaceuticals, Corbus Pharmaceuticals, and others, are developing therapies for the Medical Marijuana treatment
• Emerging Medical Marijuana therapies in the different phases of clinical trials are- INM-088, CS-S/BCC-1, TN-TC11G, CNTX-6016, EHP-101, BTX1801, Zygel, Lenabasum, and others are expected to have a significant impact on the Medical Marijuana market in the coming years.
• In November 2024, The U.S. Food and Drug Administration (FDA) Division of Psychiatry Products approved the Multidisciplinary Association for Psychedelic Studies (MAPS) to proceed with its Phase 2 trial (MJP2) evaluating smoked cannabiis for PTSD treatment in veterans. Initially placed on partial clinical hold in 2021, MJP2 is a randomized, placebo-controlled study involving 320 veterans with moderate to severe PTSD who have previously used cannabiis. Funded by the Michigan Veteran Marijuana Research Grant Program, the trial aims to assess the effects of dried cannabiis flower compared to a placebo, with participants self-titrating their daily dosage.

Medical Marijuana Overview
Medical Marijuana refers to the use of cannabiis and its compounds, for therapeutic purposes under medical supervision. It is prescribed to alleviate symptoms of various conditions, including chronic pain, epilepsy, multiple sclerosis, nausea from chemotherapy, and PTSD. Medical marijuana can be consumed in different forms, such as oils, tinctures, edibles, or inhalation. Its legality and availability vary by country and region, with regulations governing its prescription and usage.

Get a Free Sample PDF Report to know more about Medical Marijuana Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/medical-marijuana-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Medical Marijuana Drugs Under Different Phases of Clinical Development Include:
• INM-088: InMed Pharmaceuticals
• TN-TC11G: Tilray
• CNTX-6016: Centrexion Therapeutics
• EHP-101: Emerald Health
• BTX1801: Botanix Pharmaceuticals
• Zygel: Zynerba Pharmaceuticals
• Lenabasum: Corbus Pharmaceuticals

Medical Marijuana Route of Administration
Medical Marijuana pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical.
• Molecule Type

Medical Marijuana Molecule Type
Medical Marijuana Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type

Medical Marijuana Pipeline Therapeutics Assessment
• Medical Marijuana Assessment by Product Type
• Medical Marijuana By Stage and Product Type
• Medical Marijuana Assessment by Route of Administration
• Medical Marijuana By Stage and Route of Administration
• Medical Marijuana Assessment by Molecule Type
• Medical Marijuana by Stage and Molecule Type

DelveInsight's Medical Marijuana Report covers around 50+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Medical Marijuana product details are provided in the report. Download the Medical Marijuana pipeline report to learn more about the emerging Medical Marijuana therapies
https://www.delveinsight.com/sample-request/medical-marijuana-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Medical Marijuana Therapeutics Market include:
Key companies developing therapies for Medical Marijuana are - Aurora Inc., Canopy Growth Corp., Charlottes Web Holdings Inc., Columbia Care Inc., Cresco Labs LLC, Cronos Group Inc., Curaleaf Holdings Inc., Folium Biosciences, Green Roads Inc., Jazz Pharmaceuticals Plc, Lexaria Bioscience Corp., Medical Marijuana Inc., MM Enterprises USA LLC, Sundial Growers Inc., Terrascend Canada, Tilray Brands Inc., Trulieve Corp., Unrivaled Brands Inc, Verano Holdings LLC, and others.

Medical Marijuana Pipeline Analysis:
The Medical Marijuana pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Medical Marijuana with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Medical Marijuana Treatment.
• Medical Marijuana key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Medical Marijuana Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Medical Marijuana market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Medical Marijuana drugs and therapies
https://www.delveinsight.com/sample-request/medical-marijuana-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Medical Marijuana Pipeline Market Drivers
• Effective and Safe Therapeutic Agent, rise in geriatric patient population are some of the important factors that are fueling the Medical Marijuana Market.

Medical Marijuana Pipeline Market Barriers
• However, barriers to entry due to high regulations, inadequate scientific evidence and other factors are creating obstacles in the Medical Marijuana Market growth.

Scope of Medical Marijuana Pipeline Drug Insight
• Coverage: Global
• Key Medical Marijuana Companies: InMed Pharmaceuticals, Tilray, Centrexion Therapeutics, Emerald Health, Botanix Pharmaceuticals, Zynerba Pharmaceuticals, Corbus Pharmaceuticals, and others
• Key Medical Marijuana Therapies: INM-088, CS-S/BCC-1, TN-TC11G, CNTX-6016, EHP-101, BTX1801, Zygel, Lenabasum, and others
• Medical Marijuana Therapeutic Assessment: Medical Marijuana current marketed and Medical Marijuana emerging therapies
• Medical Marijuana Market Dynamics: Medical Marijuana market drivers and Medical Marijuana market barriers

Request for Sample PDF Report for Medical Marijuana Pipeline Assessment and clinical trials
https://www.delveinsight.com/sample-request/medical-marijuana-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Medical Marijuana Report Introduction
2. Medical Marijuana Executive Summary
3. Medical Marijuana Overview
4. Medical Marijuana- Analytical Perspective In-depth Commercial Assessment
5. Medical Marijuana Pipeline Therapeutics
6. Medical Marijuana Late Stage Products (Phase II/III)
7. Medical Marijuana Mid Stage Products (Phase II)
8. Medical Marijuana Early Stage Products (Phase I)
9. Medical Marijuana Preclinical Stage Products
10. Medical Marijuana Therapeutics Assessment
11. Medical Marijuana Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Medical Marijuana Key Companies
14. Medical Marijuana Key Products
15. Medical Marijuana Unmet Needs
16 . Medical Marijuana Market Drivers and Barriers
17. Medical Marijuana Future Perspectives and Conclusion
18. Medical Marijuana Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Medical Marijuana Market https://www.delveinsight.com/report-store/medical-marijuana-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Medical Marijuana Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom).

Latest Reports:
• Acute Radiation Syndrome Market: https://www.delveinsight.com/report-store/acute-radiation-syndrome-pipeline-insight
• Human Papillomavirus Hpv Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Interspinous Spacers Market: https://www.delveinsight.com/report-store/interspinous-spacers-market
• Dengue Fever Market: https://www.delveinsight.com/report-store/dengue-fever-market
• Chronic Hemodialysis Market: https://www.delveinsight.com/report-store/chronic-hemodialysis-market

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting-services

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Health careConsulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.